IPC
KYTH

Independent Portfolio Consultants’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Independent Portfolio Consultants’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-45
Closed -$2K – 1074
2014
Q4 		$2K Buy
+45
New +$1.57K ﹤0.01% 779

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Independent Portfolio Consultants's KYTH Position: Q1 2015 in Review

Independent Portfolio Consultants sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q1 2015, closing a stake of 45 shares — an estimated $2K sold.

Independent Portfolio Consultants first reported a position in KYTH in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 126 funds tracked by Wall St. Rank hold KYTH as of Q1 2015.

  • Independent Portfolio Consultants reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q1 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 45 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q1 2015, an estimated $2K.
  • Independent Portfolio Consultants first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2014 and held it in 1 quarter.
  • Independent Portfolio Consultants's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2K in Q4 2014.
  • 126 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2015.

Based on Independent Portfolio Consultants's 13F filing for Q1 2015, filed 27 May 2015.